US$ 29.71
glp-1 agonist history Agonists - What is it? glp-1_analogs [TUSOM | Pharmwiki]
Description
Patients: Adults 18 years eligible for anti-obesity medication
![glp-1 agonist history Agonists - What is it? glp-1_analogs [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c)
If you live with type 1 diabetes, chances are you've heard about GLP-1 medications Ozempic, Wegovy, Mounjaro mostly in the context of weight loss or type 2 diabetes
![glp-1 agonist history Agonists - What is it? glp-1_analogs [TUSOM | Pharmwiki]](https://www.researchgate.net/publication/390694544/figure/fig2/AS:11431281372713425@1744424615848/A-timeline-of-GLP-1-discovery-and-clinical-development-Created-in-BioRender-Anastasiou.png)
By distribution channel, retail chain pharmacies captured 61.24% revenue in 2025, while e-commerce and tele-pharmacy platforms are poised for a 12.79% CAGR through 2031
![glp-1 agonist history Agonists - What is it? glp-1_analogs [TUSOM | Pharmwiki]](https://ars.els-cdn.com/content/image/1-s2.0-S1043661825004700-gr1.jpg)
The FDA is offering a 60- to 90-day grace period before compounders have to stop manufacturing tirzepatide to minimise disruption for patients
![glp-1 agonist history Agonists - What is it? glp-1_analogs [TUSOM | Pharmwiki]](https://www.frontiersin.org/api/ipx/w=1200&f=png/https://www.frontiersin.org/files/Articles/1675552/fphar-16-1675552-HTML/image_m/fphar-16-1675552-g001.jpg)
[Google Scholar] [22].Yang XD, Yang YY
![glp-1 agonist history Agonists - What is it? glp-1_analogs [TUSOM | Pharmwiki]](https://www.coherentmarketinsights.com/images/research-%20methodology/glp-1-receptor-agonist-market-key-factors.jpg)
Other supplements that support metabolic function during weight loss include B12, which is commonly compounded with GLP-1 medications
![glp-1 agonist history Agonists - What is it? glp-1_analogs [TUSOM | Pharmwiki]](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs40265-025-02263-0/MediaObjects/40265_2025_2263_Fig1_HTML.png)